| 英文别名 |
7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one;7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one;7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(3H)-quinazolinone;7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one;7-methoxy-6-(3-morpholin-4-ylpropoxy)-1H-quinazolin-4-one;7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;7-Methoxy-6-(3-Morpholin-4-ylpropoxy)quinazolin;7-Methoxy-6-(3-morpholinopropoxy)-quinazolin-4(3H)-one;4(1H)-Quinazolinone,7-methoxy-6-[3-(4-morpholinyl)propoxy]- (9CI);4(3H)-Quinazolinone,7-methoxy-6-[3-(4-morpholinyl)propoxy]-;quinazolin-4(3H);Gefitinib iMpurity F;Gefitinib Impurity 8;Gefitinib Impurity 14;Getitinib interMediate;InterMediate of Gefitinib;7-Methoxy-6-(3-morpholinopropoxy);6-(3-morpholinopropoxy)-7-methoxyquinazolin-4(3H)-one;Gefintinib Impurity 5;7-methoxy-6-[3-(morpholin-4-yl)propoxy]-3,4-dihydroquinazolin-4-one;4(3H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-;A18404;WFUBWLXSYCFZEH-UHFFFAOYSA-N;199327-61-2;UNII-R9YH59H93M;7-Methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(3H)-one;EC 429-400-7;DTXSID90439401;AKOS015917892;DS-1851;7-methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin4-one;AC-22622;SCHEMBL829762;MFCD12760130;Q-101334;Gefitinib Impurity 12;7-Methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(1H)-one;AM20090617;4(1H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-;CS-0131955;BCP26350;Gefitinib related compound A [USP];NS00077739;R9YH59H93M;7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(1H)-quinazolinone;FT-0660445;AKOS025401601;SY039369;HY-133779;FD16024;Gefitinib Impurity 5;7-Methoxy-6-(3-(4-morpholinyl)propoxy)-4(3H)-quinazolinone;SCHEMBL25281864;7-methoxy-6-(3-morpholin-4-ylpropoxy)-3H-quinazolin-4-one;DB-066001;7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(1h)-one;7-METHOXY-6-[3-(MORPHOLIN-4-YL)PROPOXY]-3H-QUINAZOLIN-4-ONE |